Novartis Ag (NVS) Treasury Shares (2009 - 2026)

Novartis Ag (NVS) has 13 years of Treasury Shares data on file, last reported at -$47.0 million in Q1 2026.

• Quarterly Treasury Shares fell 147.37% year-over-year to -$47.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$47.0 million (down 147.37% YoY) and the FY2025 annual result came in at -$50.0 million, up 5.66% from the prior year.
• Treasury Shares climbed to -$47.0 million in Q1 2026 per NVS's latest filing, from -$50.0 million in the prior quarter.
• The five-year high for Treasury Shares was -$3.0 million in Q4 2019, with the low at -$2.7 billion in Q2 2022.
• Average Treasury Shares over 4 years is -$529.8 million, with a median of -$186.0 million recorded in 2019.
• Year-over-year, Treasury Shares surged 91.67% in 2022 and slumped 229.27% in 2024.
• Novartis Ag's Treasury Shares stood at $92.0 million in 2022, then tumbled by 55.43% to $41.0 million in 2023, then tumbled by 229.27% to -$53.0 million in 2024, then increased by 5.66% to -$50.0 million in 2025, then grew by 6.0% to -$47.0 million in 2026.
• Business Quant data shows NVS's Treasury Shares at -$47.0 million in Q1 2026, -$50.0 million in Q4 2025, and -$44.0 million in Q3 2025.